MedTrace Logo

Norepinephrine Consumption After Prophylactic Ondansetron

NCT02928601 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 108

Last updated 2017-08-22

No results posted yet for this study

Summary

This study evaluates the effect of prophylactic ondansetron on the incidence of spinal hypotension and vasopressor consumption in caesarean section patients using norepinephrine treatment. Half of participants receive ondansetron before spinal anesthesia while the other half receive saline.

Conditions

  • Maternal Hypotension

Interventions

DRUG

Ondansetron

After spinal anesthesia, half of the patients will be given intravenous 8 mg ondansetron.

DRUG

Saline

After spinal anesthesia, half of the patients will be given intravenous 2 mlt saline.

Sponsors & Collaborators

  • Cukurova University

    lead OTHER

Principal Investigators

  • Hakkı Ünlügenç, Professor · Cukurova University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-11-30
Primary Completion
2017-08-31
Completion
2017-08-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02928601 on ClinicalTrials.gov